Selected research
Industry Research
Anti-thrombotic Drugs Industry Research Report 2026
Market perspective
The global Anti-thrombotic Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Anti-thrombotic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Anti-thrombotic Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Anti-thrombotic Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Anti-thrombotic Drugs include Yantai Dongcheng North Pharmaceutical Co., Ltd., Tianjin Biochemical Pharmaceutical Co., Ltd., Tianjin Hongri Pharmaceutical Co., Ltd., Sichuan Changzheng Pharmaceutical Co., Ltd., Shijiazhuang Heping Pharmaceutical Factory, Shenzhen Saibaoer Biopharmaceutical Co., Ltd., Shandong Xinshidai Pharmaceutical Co., Ltd., Shandong Lvyin Pharmaceutical Co., Ltd. and Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Anti-thrombotic Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Anti-thrombotic Drugs Market by Company
Yantai Dongcheng North Pharmaceutical Co., Ltd.
Tianjin Biochemical Pharmaceutical Co., Ltd.
Tianjin Hongri Pharmaceutical Co., Ltd.
Sichuan Changzheng Pharmaceutical Co., Ltd.
Shijiazhuang Heping Pharmaceutical Factory
Shenzhen Saibaoer Biopharmaceutical Co., Ltd.
Shandong Xinshidai Pharmaceutical Co., Ltd.
Shandong Lvyin Pharmaceutical Co., Ltd.
Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd.
Henan Yonghe Pharmaceutical Co., Ltd.
Chengdu Yuandong Biopharmaceutical Co., Ltd.
Chengdu Tongde Pharmaceutical Co., Ltd.
Chengdu Baiyu Pharmaceutical Co., Ltd.
Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd.
Beijing Taide Pharmaceutical Co., Ltd.
Beijing Shuanglu Pharmaceutical Co., Ltd.
Beijing Chengji Pharmaceutical Co., Ltd.
Teva
Sanofi
Sandoz
Pfizer
Johnson & Johnson
GlaxoSmithKline
Daiichi Sankyo
Bristol Myers Squibb
Boehringer Ingelheim Pharmaceuticals
Bayer
Anti-thrombotic Drugs Segment by Type
Platelet Aggregation Inhibitors
Enzymes
Heparins
Other
Anti-thrombotic Drugs Segment by Application
Clinic
Hospital
Other
Anti-thrombotic Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-thrombotic Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anti-thrombotic Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-thrombotic Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Anti-thrombotic Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Anti-thrombotic Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Anti-thrombotic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Anti-thrombotic Drugs Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025)
Table 6. Global Anti-thrombotic Drugs Sales (K Units) of Manufacturers (2021-2026)
Table 7. Global Anti-thrombotic Drugs Sales Market Share by Manufacturers (2021-2026)
Table 8. Global Anti-thrombotic Drugs Revenue of Manufacturers (2021-2026)
Table 9. Global Anti-thrombotic Drugs Revenue Share by Manufacturers (2021-2026)
Table 10. Global Market Anti-thrombotic Drugs Average Price (US$/Unit) of Manufacturers (2021-2026)
Table 11. Global Anti-thrombotic Drugs Industry Ranking, 2024 VS 2025 VS 2026
Table 12. Global Manufacturers of Anti-thrombotic Drugs, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Anti-thrombotic Drugs, Product Type & Application
Table 14. Global Anti-thrombotic Drugs Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Anti-thrombotic Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. Yantai Dongcheng North Pharmaceutical Co., Ltd. Company Information
Table 19. Yantai Dongcheng North Pharmaceutical Co., Ltd. Business Overview
Table 20. Yantai Dongcheng North Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 21. Yantai Dongcheng North Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
Table 22. Yantai Dongcheng North Pharmaceutical Co., Ltd. Recent Developments
Table 23. Tianjin Biochemical Pharmaceutical Co., Ltd. Company Information
Table 24. Tianjin Biochemical Pharmaceutical Co., Ltd. Business Overview
Table 25. Tianjin Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 26. Tianjin Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
Table 27. Tianjin Biochemical Pharmaceutical Co., Ltd. Recent Developments
Table 28. Tianjin Hongri Pharmaceutical Co., Ltd. Company Information
Table 29. Tianjin Hongri Pharmaceutical Co., Ltd. Business Overview
Table 30. Tianjin Hongri Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 31. Tianjin Hongri Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
Table 32. Tianjin Hongri Pharmaceutical Co., Ltd. Recent Developments
Table 33. Sichuan Changzheng Pharmaceutical Co., Ltd. Company Information
Table 34. Sichuan Changzheng Pharmaceutical Co., Ltd. Business Overview
Table 35. Sichuan Changzheng Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 36. Sichuan Changzheng Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
Table 37. Sichuan Changzheng Pharmaceutical Co., Ltd. Recent Developments
Table 38. Shijiazhuang Heping Pharmaceutical Factory Company Information
Table 39. Shijiazhuang Heping Pharmaceutical Factory Business Overview
Table 40. Shijiazhuang Heping Pharmaceutical Factory Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 41. Shijiazhuang Heping Pharmaceutical Factory Anti-thrombotic Drugs Product Portfolio
Table 42. Shijiazhuang Heping Pharmaceutical Factory Recent Developments
Table 43. Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Company Information
Table 44. Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Business Overview
Table 45. Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 46. Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
Table 47. Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Recent Developments
Table 48. Shandong Xinshidai Pharmaceutical Co., Ltd. Company Information
Table 49. Shandong Xinshidai Pharmaceutical Co., Ltd. Business Overview
Table 50. Shandong Xinshidai Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 51. Shandong Xinshidai Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
Table 52. Shandong Xinshidai Pharmaceutical Co., Ltd. Recent Developments
Table 53. Shandong Lvyin Pharmaceutical Co., Ltd. Company Information
Table 54. Shandong Lvyin Pharmaceutical Co., Ltd. Business Overview
Table 55. Shandong Lvyin Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 56. Shandong Lvyin Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
Table 57. Shandong Lvyin Pharmaceutical Co., Ltd. Recent Developments
Table 58. Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Company Information
Table 59. Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Business Overview
Table 60. Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 61. Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
Table 62. Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Recent Developments
Table 63. Henan Yonghe Pharmaceutical Co., Ltd. Company Information
Table 64. Henan Yonghe Pharmaceutical Co., Ltd. Business Overview
Table 65. Henan Yonghe Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 66. Henan Yonghe Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
Table 67. Henan Yonghe Pharmaceutical Co., Ltd. Recent Developments
Table 68. Chengdu Yuandong Biopharmaceutical Co., Ltd. Company Information
Table 69. Chengdu Yuandong Biopharmaceutical Co., Ltd. Business Overview
Table 70. Chengdu Yuandong Biopharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 71. Chengdu Yuandong Biopharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
Table 72. Chengdu Yuandong Biopharmaceutical Co., Ltd. Recent Developments
Table 73. Chengdu Tongde Pharmaceutical Co., Ltd. Company Information
Table 74. Chengdu Tongde Pharmaceutical Co., Ltd. Business Overview
Table 75. Chengdu Tongde Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Chengdu Tongde Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
Table 77. Chengdu Tongde Pharmaceutical Co., Ltd. Recent Developments
Table 78. Chengdu Baiyu Pharmaceutical Co., Ltd. Company Information
Table 79. Chengdu Baiyu Pharmaceutical Co., Ltd. Business Overview
Table 80. Chengdu Baiyu Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Chengdu Baiyu Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
Table 82. Chengdu Baiyu Pharmaceutical Co., Ltd. Recent Developments
Table 83. Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Company Information
Table 84. Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Business Overview
Table 85. Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
Table 87. Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Recent Developments
Table 88. Beijing Taide Pharmaceutical Co., Ltd. Company Information
Table 89. Beijing Taide Pharmaceutical Co., Ltd. Business Overview
Table 90. Beijing Taide Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Beijing Taide Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
Table 92. Beijing Taide Pharmaceutical Co., Ltd. Recent Developments
Table 93. Beijing Shuanglu Pharmaceutical Co., Ltd. Company Information
Table 94. Beijing Shuanglu Pharmaceutical Co., Ltd. Business Overview
Table 95. Beijing Shuanglu Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Beijing Shuanglu Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
Table 97. Beijing Shuanglu Pharmaceutical Co., Ltd. Recent Developments
Table 98. Beijing Chengji Pharmaceutical Co., Ltd. Company Information
Table 99. Beijing Chengji Pharmaceutical Co., Ltd. Business Overview
Table 100. Beijing Chengji Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Beijing Chengji Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
Table 102. Beijing Chengji Pharmaceutical Co., Ltd. Recent Developments
Table 103. Teva Company Information
Table 104. Teva Business Overview
Table 105. Teva Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Teva Anti-thrombotic Drugs Product Portfolio
Table 107. Teva Recent Developments
Table 108. Sanofi Company Information
Table 109. Sanofi Business Overview
Table 110. Sanofi Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Sanofi Anti-thrombotic Drugs Product Portfolio
Table 112. Sanofi Recent Developments
Table 113. Sandoz Company Information
Table 114. Sandoz Business Overview
Table 115. Sandoz Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Sandoz Anti-thrombotic Drugs Product Portfolio
Table 117. Sandoz Recent Developments
Table 118. Pfizer Company Information
Table 119. Pfizer Business Overview
Table 120. Pfizer Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Pfizer Anti-thrombotic Drugs Product Portfolio
Table 122. Pfizer Recent Developments
Table 123. Johnson & Johnson Company Information
Table 124. Johnson & Johnson Business Overview
Table 125. Johnson & Johnson Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Johnson & Johnson Anti-thrombotic Drugs Product Portfolio
Table 127. Johnson & Johnson Recent Developments
Table 128. GlaxoSmithKline Company Information
Table 129. GlaxoSmithKline Business Overview
Table 130. GlaxoSmithKline Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. GlaxoSmithKline Anti-thrombotic Drugs Product Portfolio
Table 132. GlaxoSmithKline Recent Developments
Table 133. Daiichi Sankyo Company Information
Table 134. Daiichi Sankyo Business Overview
Table 135. Daiichi Sankyo Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. Daiichi Sankyo Anti-thrombotic Drugs Product Portfolio
Table 137. Daiichi Sankyo Recent Developments
Table 138. Bristol Myers Squibb Company Information
Table 139. Bristol Myers Squibb Business Overview
Table 140. Bristol Myers Squibb Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 141. Bristol Myers Squibb Anti-thrombotic Drugs Product Portfolio
Table 142. Bristol Myers Squibb Recent Developments
Table 143. Boehringer Ingelheim Pharmaceuticals Company Information
Table 144. Boehringer Ingelheim Pharmaceuticals Business Overview
Table 145. Boehringer Ingelheim Pharmaceuticals Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 146. Boehringer Ingelheim Pharmaceuticals Anti-thrombotic Drugs Product Portfolio
Table 147. Boehringer Ingelheim Pharmaceuticals Recent Developments
Table 148. Bayer Company Information
Table 149. Bayer Business Overview
Table 150. Bayer Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 151. Bayer Anti-thrombotic Drugs Product Portfolio
Table 152. Bayer Recent Developments
Table 153. Global Anti-thrombotic Drugs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 154. Global Anti-thrombotic Drugs Sales by Region (2021-2026) & (K Units)
Table 155. Global Anti-thrombotic Drugs Sales Market Share by Region (2021-2026)
Table 156. Global Anti-thrombotic Drugs Sales by Region (2027-2032) & (K Units)
Table 157. Global Anti-thrombotic Drugs Sales Market Share by Region (2027-2032)
Table 158. Global Anti-thrombotic Drugs Revenue by Region (2021-2026) & (US$ Million)
Table 159. Global Anti-thrombotic Drugs Revenue Market Share by Region (2021-2026)
Table 160. Global Anti-thrombotic Drugs Revenue by Region (2027-2032) & (US$ Million)
Table 161. Global Anti-thrombotic Drugs Revenue Market Share by Region (2027-2032)
Table 162. North America Anti-thrombotic Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 163. North America Anti-thrombotic Drugs Sales by Country (2021-2026) & (K Units)
Table 164. North America Anti-thrombotic Drugs Sales by Country (2027-2032) & (K Units)
Table 165. North America Anti-thrombotic Drugs Revenue by Country (2021-2026) & (US$ Million)
Table 166. North America Anti-thrombotic Drugs Revenue by Country (2027-2032) & (US$ Million)
Table 167. Europe Anti-thrombotic Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 168. Europe Anti-thrombotic Drugs Sales by Country (2021-2026) & (K Units)
Table 169. Europe Anti-thrombotic Drugs Sales by Country (2027-2032) & (K Units)
Table 170. Europe Anti-thrombotic Drugs Revenue by Country (2021-2026) & (US$ Million)
Table 171. Europe Anti-thrombotic Drugs Revenue by Country (2027-2032) & (US$ Million)
Table 172. Asia Pacific Anti-thrombotic Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 173. Asia Pacific Anti-thrombotic Drugs Sales by Country (2021-2026) & (K Units)
Table 174. Asia Pacific Anti-thrombotic Drugs Sales by Country (2027-2032) & (K Units)
Table 175. Asia Pacific Anti-thrombotic Drugs Revenue by Country (2021-2026) & (US$ Million)
Table 176. Asia Pacific Anti-thrombotic Drugs Revenue by Country (2027-2032) & (US$ Million)
Table 177. South America Anti-thrombotic Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 178. South America Anti-thrombotic Drugs Sales by Country (2021-2026) & (K Units)
Table 179. South America Anti-thrombotic Drugs Sales by Country (2027-2032) & (K Units)
Table 180. South America Anti-thrombotic Drugs Revenue by Country (2021-2026) & (US$ Million)
Table 181. South America Anti-thrombotic Drugs Revenue by Country (2027-2032) & (US$ Million)
Table 182. Middle East and Africa Anti-thrombotic Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 183. Middle East and Africa Anti-thrombotic Drugs Sales by Country (2021-2026) & (K Units)
Table 184. Middle East and Africa Anti-thrombotic Drugs Sales by Country (2027-2032) & (K Units)
Table 185. Middle East and Africa Anti-thrombotic Drugs Revenue by Country (2021-2026) & (US$ Million)
Table 186. Middle East and Africa Anti-thrombotic Drugs Revenue by Country (2027-2032) & (US$ Million)
Table 187. Global Anti-thrombotic Drugs Sales by Type (2021-2026) & (K Units)
Table 188. Global Anti-thrombotic Drugs Sales by Type (2027-2032) & (K Units)
Table 189. Global Anti-thrombotic Drugs Sales Market Share by Type (2021-2026)
Table 190. Global Anti-thrombotic Drugs Sales Market Share by Type (2027-2032)
Table 191. Global Anti-thrombotic Drugs Revenue by Type (2021-2026) & (US$ Million)
Table 192. Global Anti-thrombotic Drugs Revenue by Type (2027-2032) & (US$ Million)
Table 193. Global Anti-thrombotic Drugs Revenue Market Share by Type (2021-2026)
Table 194. Global Anti-thrombotic Drugs Revenue Market Share by Type (2027-2032)
Table 195. Global Anti-thrombotic Drugs Price by Type (2021-2026) & (US$/Unit)
Table 196. Global Anti-thrombotic Drugs Price by Type (2027-2032) & (US$/Unit)
Table 197. Global Anti-thrombotic Drugs Sales by Application (2021-2026) & (K Units)
Table 198. Global Anti-thrombotic Drugs Sales by Application (2027-2032) & (K Units)
Table 199. Global Anti-thrombotic Drugs Sales Market Share by Application (2021-2026)
Table 200. Global Anti-thrombotic Drugs Sales Market Share by Application (2027-2032)
Table 201. Global Anti-thrombotic Drugs Revenue by Application (2021-2026) & (US$ Million)
Table 202. Global Anti-thrombotic Drugs Revenue by Application (2027-2032) & (US$ Million)
Table 203. Global Anti-thrombotic Drugs Revenue Market Share by Application (2021-2026)
Table 204. Global Anti-thrombotic Drugs Revenue Market Share by Application (2027-2032)
Table 205. Global Anti-thrombotic Drugs Price by Application (2021-2026) & (US$/Unit)
Table 206. Global Anti-thrombotic Drugs Price by Application (2027-2032) & (US$/Unit)
Table 207. Key Raw Materials
Table 208. Raw Materials Key Suppliers
Table 209. Anti-thrombotic Drugs Distributors List
Table 210. Anti-thrombotic Drugs Customers List
Table 211. Anti-thrombotic Drugs Industry Trends
Table 212. Anti-thrombotic Drugs Industry Drivers
Table 213. Anti-thrombotic Drugs Industry Restraints
Table 214. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Anti-thrombotic Drugs Product Image
Figure 5. Global Anti-thrombotic Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032
Figure 6. Global Anti-thrombotic Drugs Market Size (2021-2032) & (US$ Million)
Figure 7. Global Anti-thrombotic Drugs Sales (2021-2032) & (K Units)
Figure 8. Global Anti-thrombotic Drugs Average Price (US$/Unit) & (2021-2032)
Figure 9. Platelet Aggregation Inhibitors Product Image
Figure 10. Enzymes Product Image
Figure 11. Heparins Product Image
Figure 12. Other Product Image
Figure 13. Clinic Product Image
Figure 14. Hospital Product Image
Figure 15. Other Product Image
Figure 16. Global Anti-thrombotic Drugs Revenue Share by Manufacturers in 2025
Figure 17. Global Manufacturers of Anti-thrombotic Drugs, Manufacturing Sites & Headquarters
Figure 18. Global Top 5 and 10 Anti-thrombotic Drugs Players Market Share by Revenue in 2025
Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 20. Global Anti-thrombotic Drugs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Figure 21. Global Anti-thrombotic Drugs Sales by Region in 2025
Figure 22. Global Anti-thrombotic Drugs Revenue by Region in 2025
Figure 23. North America Anti-thrombotic Drugs Market Size by Country in 2025
Figure 24. North America Anti-thrombotic Drugs Sales Market Share by Country (2021-2032)
Figure 25. North America Anti-thrombotic Drugs Revenue Market Share by Country (2021-2032)
Figure 26. United States Anti-thrombotic Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 27. Canada Anti-thrombotic Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 28. Mexico Anti-thrombotic Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 29. Europe Anti-thrombotic Drugs Market Size by Country in 2025
Figure 30. Europe Anti-thrombotic Drugs Sales Market Share by Country (2021-2032)
Figure 31. Europe Anti-thrombotic Drugs Revenue Market Share by Country (2021-2032)
Figure 32. Germany Anti-thrombotic Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 33. France Anti-thrombotic Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 34. U.K. Anti-thrombotic Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 35. Italy Anti-thrombotic Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 36. Russia Anti-thrombotic Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 37. Spain Anti-thrombotic Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 38. Netherlands Anti-thrombotic Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 39. Switzerland Anti-thrombotic Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 40. Sweden Anti-thrombotic Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 41. Poland Anti-thrombotic Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 42. Asia Pacific Anti-thrombotic Drugs Market Size by Country in 2025
Figure 43. Asia Pacific Anti-thrombotic Drugs Sales Market Share by Country (2021-2032)
Figure 44. Asia Pacific Anti-thrombotic Drugs Revenue Market Share by Country (2021-2032)
Figure 45. China Anti-thrombotic Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 46. Japan Anti-thrombotic Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 47. South Korea Anti-thrombotic Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 48. India Anti-thrombotic Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 49. Australia Anti-thrombotic Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 50. Taiwan Anti-thrombotic Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 51. Southeast Asia Anti-thrombotic Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 52. Southeast Asia Anti-thrombotic Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 53. South America Anti-thrombotic Drugs Market Size by Country in 2025
Figure 54. South America Anti-thrombotic Drugs Sales Market Share by Country (2021-2032)
Figure 55. South America Anti-thrombotic Drugs Revenue Market Share by Country (2021-2032)
Figure 56. Brazil Anti-thrombotic Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 57. Argentina Anti-thrombotic Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 58. Chile Anti-thrombotic Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 59. Middle East and Africa Anti-thrombotic Drugs Market Size by Country in 2025
Figure 60. Middle East and Africa Anti-thrombotic Drugs Sales Market Share by Country (2021-2032)
Figure 61. Middle East and Africa Anti-thrombotic Drugs Revenue Market Share by Country (2021-2032)
Figure 62. Egypt Anti-thrombotic Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 63. South Africa Anti-thrombotic Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 64. Israel Anti-thrombotic Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 65. Türkiye Anti-thrombotic Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 66. GCC Countries Anti-thrombotic Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 67. Global Anti-thrombotic Drugs Sales Market Share by Type (2021-2032)
Figure 68. Global Anti-thrombotic Drugs Revenue Market Share by Type (2021-2032)
Figure 69. Global Anti-thrombotic Drugs Price (US$/Unit) by Type (2021-2032)
Figure 70. Global Anti-thrombotic Drugs Sales Market Share by Application (2021-2032)
Figure 71. Global Anti-thrombotic Drugs Revenue Market Share by Application (2021-2032)
Figure 72. Global Anti-thrombotic Drugs Price (US$/Unit) by Application (2021-2032)
Figure 73. Anti-thrombotic Drugs Value Chain
Figure 74. Anti-thrombotic Drugs Production Mode & Process
Figure 75. Direct Comparison with Distribution Share
Figure 76. Distributors Profiles
Figure 77. Anti-thrombotic Drugs Industry Opportunities and Challenges
Scope & coverage.
Types
- Platelet Aggregation Inhibitors
- Enzymes
- Heparins
- Other
Applications
- Clinic
- Hospital
- Other
Companies covered
- Yantai Dongcheng North Pharmaceutical Co., Ltd.
- Tianjin Biochemical Pharmaceutical Co., Ltd.
- Tianjin Hongri Pharmaceutical Co., Ltd.
- Sichuan Changzheng Pharmaceutical Co., Ltd.
- Shijiazhuang Heping Pharmaceutical Factory
- Shenzhen Saibaoer Biopharmaceutical Co., Ltd.
- Shandong Xinshidai Pharmaceutical Co., Ltd.
- Shandong Lvyin Pharmaceutical Co., Ltd.
- Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd.
- Henan Yonghe Pharmaceutical Co., Ltd.
- Chengdu Yuandong Biopharmaceutical Co., Ltd.
- Chengdu Tongde Pharmaceutical Co., Ltd.
- Chengdu Baiyu Pharmaceutical Co., Ltd.
- Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd.
- Beijing Taide Pharmaceutical Co., Ltd.
- Beijing Shuanglu Pharmaceutical Co., Ltd.
- Beijing Chengji Pharmaceutical Co., Ltd.
- Teva
- Sanofi
- Sandoz
- Pfizer
- Johnson & Johnson
- GlaxoSmithKline
- Daiichi Sankyo
- Bristol Myers Squibb
- Boehringer Ingelheim Pharmaceuticals
- Bayer
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Anti-thrombotic Drugs Market Size (2021-2032)
- 2.2.2 Global Anti-thrombotic Drugs Sales (2021-2032)
- 2.2.3 Global Anti-thrombotic Drugs Market Average Price (2021-2032)
- 2.3 Anti-thrombotic Drugs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Platelet Aggregation Inhibitors
- 2.3.3 Enzymes
- 2.3.4 Heparins
- 2.3.5 Other
- 2.4 Anti-thrombotic Drugs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Clinic
- 2.4.3 Hospital
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Anti-thrombotic Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Anti-thrombotic Drugs Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Anti-thrombotic Drugs Revenue of Manufacturers (2021-2026)
- 3.4 Global Anti-thrombotic Drugs Average Price by Manufacturers (2021-2026)
- 3.5 Global Anti-thrombotic Drugs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Anti-thrombotic Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Anti-thrombotic Drugs, Product Type & Application
- 3.8 Global Manufacturers of Anti-thrombotic Drugs, Established Date
- 3.9 Global Anti-thrombotic Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Yantai Dongcheng North Pharmaceutical Co., Ltd.
- 4.1.1 Yantai Dongcheng North Pharmaceutical Co., Ltd. Company Information
- 4.1.2 Yantai Dongcheng North Pharmaceutical Co., Ltd. Business Overview
- 4.1.3 Yantai Dongcheng North Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Yantai Dongcheng North Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
- 4.1.5 Yantai Dongcheng North Pharmaceutical Co., Ltd. Recent Developments
- 4.2 Tianjin Biochemical Pharmaceutical Co., Ltd.
- 4.2.1 Tianjin Biochemical Pharmaceutical Co., Ltd. Company Information
- 4.2.2 Tianjin Biochemical Pharmaceutical Co., Ltd. Business Overview
- 4.2.3 Tianjin Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Tianjin Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
- 4.2.5 Tianjin Biochemical Pharmaceutical Co., Ltd. Recent Developments
- 4.3 Tianjin Hongri Pharmaceutical Co., Ltd.
- 4.3.1 Tianjin Hongri Pharmaceutical Co., Ltd. Company Information
- 4.3.2 Tianjin Hongri Pharmaceutical Co., Ltd. Business Overview
- 4.3.3 Tianjin Hongri Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Tianjin Hongri Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
- 4.3.5 Tianjin Hongri Pharmaceutical Co., Ltd. Recent Developments
- 4.4 Sichuan Changzheng Pharmaceutical Co., Ltd.
- 4.4.1 Sichuan Changzheng Pharmaceutical Co., Ltd. Company Information
- 4.4.2 Sichuan Changzheng Pharmaceutical Co., Ltd. Business Overview
- 4.4.3 Sichuan Changzheng Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Sichuan Changzheng Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
- 4.4.5 Sichuan Changzheng Pharmaceutical Co., Ltd. Recent Developments
- 4.5 Shijiazhuang Heping Pharmaceutical Factory
- 4.5.1 Shijiazhuang Heping Pharmaceutical Factory Company Information
- 4.5.2 Shijiazhuang Heping Pharmaceutical Factory Business Overview
- 4.5.3 Shijiazhuang Heping Pharmaceutical Factory Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Shijiazhuang Heping Pharmaceutical Factory Anti-thrombotic Drugs Product Portfolio
- 4.5.5 Shijiazhuang Heping Pharmaceutical Factory Recent Developments
- 4.6 Shenzhen Saibaoer Biopharmaceutical Co., Ltd.
- 4.6.1 Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Company Information
- 4.6.2 Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Business Overview
- 4.6.3 Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
- 4.6.5 Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Recent Developments
- 4.7 Shandong Xinshidai Pharmaceutical Co., Ltd.
- 4.7.1 Shandong Xinshidai Pharmaceutical Co., Ltd. Company Information
- 4.7.2 Shandong Xinshidai Pharmaceutical Co., Ltd. Business Overview
- 4.7.3 Shandong Xinshidai Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Shandong Xinshidai Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
- 4.7.5 Shandong Xinshidai Pharmaceutical Co., Ltd. Recent Developments
- 4.8 Shandong Lvyin Pharmaceutical Co., Ltd.
- 4.8.1 Shandong Lvyin Pharmaceutical Co., Ltd. Company Information
- 4.8.2 Shandong Lvyin Pharmaceutical Co., Ltd. Business Overview
- 4.8.3 Shandong Lvyin Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Shandong Lvyin Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
- 4.8.5 Shandong Lvyin Pharmaceutical Co., Ltd. Recent Developments
- 4.9 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd.
- 4.9.1 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Company Information
- 4.9.2 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Business Overview
- 4.9.3 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
- 4.9.5 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Recent Developments
- 4.10 Henan Yonghe Pharmaceutical Co., Ltd.
- 4.10.1 Henan Yonghe Pharmaceutical Co., Ltd. Company Information
- 4.10.2 Henan Yonghe Pharmaceutical Co., Ltd. Business Overview
- 4.10.3 Henan Yonghe Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Henan Yonghe Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
- 4.10.5 Henan Yonghe Pharmaceutical Co., Ltd. Recent Developments
- 4.11 Chengdu Yuandong Biopharmaceutical Co., Ltd.
- 4.11.1 Chengdu Yuandong Biopharmaceutical Co., Ltd. Company Information
- 4.11.2 Chengdu Yuandong Biopharmaceutical Co., Ltd. Business Overview
- 4.11.3 Chengdu Yuandong Biopharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Chengdu Yuandong Biopharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
- 4.11.5 Chengdu Yuandong Biopharmaceutical Co., Ltd. Recent Developments
- 4.12 Chengdu Tongde Pharmaceutical Co., Ltd.
- 4.12.1 Chengdu Tongde Pharmaceutical Co., Ltd. Company Information
- 4.12.2 Chengdu Tongde Pharmaceutical Co., Ltd. Business Overview
- 4.12.3 Chengdu Tongde Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Chengdu Tongde Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
- 4.12.5 Chengdu Tongde Pharmaceutical Co., Ltd. Recent Developments
- 4.13 Chengdu Baiyu Pharmaceutical Co., Ltd.
- 4.13.1 Chengdu Baiyu Pharmaceutical Co., Ltd. Company Information
- 4.13.2 Chengdu Baiyu Pharmaceutical Co., Ltd. Business Overview
- 4.13.3 Chengdu Baiyu Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Chengdu Baiyu Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
- 4.13.5 Chengdu Baiyu Pharmaceutical Co., Ltd. Recent Developments
- 4.14 Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd.
- 4.14.1 Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Company Information
- 4.14.2 Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Business Overview
- 4.14.3 Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
- 4.14.5 Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Recent Developments
- 4.15 Beijing Taide Pharmaceutical Co., Ltd.
- 4.15.1 Beijing Taide Pharmaceutical Co., Ltd. Company Information
- 4.15.2 Beijing Taide Pharmaceutical Co., Ltd. Business Overview
- 4.15.3 Beijing Taide Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Beijing Taide Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
- 4.15.5 Beijing Taide Pharmaceutical Co., Ltd. Recent Developments
- 4.16 Beijing Shuanglu Pharmaceutical Co., Ltd.
- 4.16.1 Beijing Shuanglu Pharmaceutical Co., Ltd. Company Information
- 4.16.2 Beijing Shuanglu Pharmaceutical Co., Ltd. Business Overview
- 4.16.3 Beijing Shuanglu Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Beijing Shuanglu Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
- 4.16.5 Beijing Shuanglu Pharmaceutical Co., Ltd. Recent Developments
- 4.17 Beijing Chengji Pharmaceutical Co., Ltd.
- 4.17.1 Beijing Chengji Pharmaceutical Co., Ltd. Company Information
- 4.17.2 Beijing Chengji Pharmaceutical Co., Ltd. Business Overview
- 4.17.3 Beijing Chengji Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Beijing Chengji Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
- 4.17.5 Beijing Chengji Pharmaceutical Co., Ltd. Recent Developments
- 4.18 Teva
- 4.18.1 Teva Company Information
- 4.18.2 Teva Business Overview
- 4.18.3 Teva Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Teva Anti-thrombotic Drugs Product Portfolio
- 4.18.5 Teva Recent Developments
- 4.19 Sanofi
- 4.19.1 Sanofi Company Information
- 4.19.2 Sanofi Business Overview
- 4.19.3 Sanofi Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.19.4 Sanofi Anti-thrombotic Drugs Product Portfolio
- 4.19.5 Sanofi Recent Developments
- 4.20 Sandoz
- 4.20.1 Sandoz Company Information
- 4.20.2 Sandoz Business Overview
- 4.20.3 Sandoz Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.20.4 Sandoz Anti-thrombotic Drugs Product Portfolio
- 4.20.5 Sandoz Recent Developments
- 4.21 Pfizer
- 4.21.1 Pfizer Company Information
- 4.21.2 Pfizer Business Overview
- 4.21.3 Pfizer Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.21.4 Pfizer Anti-thrombotic Drugs Product Portfolio
- 4.21.5 Pfizer Recent Developments
- 4.22 Johnson & Johnson
- 4.22.1 Johnson & Johnson Company Information
- 4.22.2 Johnson & Johnson Business Overview
- 4.22.3 Johnson & Johnson Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.22.4 Johnson & Johnson Anti-thrombotic Drugs Product Portfolio
- 4.22.5 Johnson & Johnson Recent Developments
- 4.23 GlaxoSmithKline
- 4.23.1 GlaxoSmithKline Company Information
- 4.23.2 GlaxoSmithKline Business Overview
- 4.23.3 GlaxoSmithKline Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.23.4 GlaxoSmithKline Anti-thrombotic Drugs Product Portfolio
- 4.23.5 GlaxoSmithKline Recent Developments
- 4.24 Daiichi Sankyo
- 4.24.1 Daiichi Sankyo Company Information
- 4.24.2 Daiichi Sankyo Business Overview
- 4.24.3 Daiichi Sankyo Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.24.4 Daiichi Sankyo Anti-thrombotic Drugs Product Portfolio
- 4.24.5 Daiichi Sankyo Recent Developments
- 4.25 Bristol Myers Squibb
- 4.25.1 Bristol Myers Squibb Company Information
- 4.25.2 Bristol Myers Squibb Business Overview
- 4.25.3 Bristol Myers Squibb Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.25.4 Bristol Myers Squibb Anti-thrombotic Drugs Product Portfolio
- 4.25.5 Bristol Myers Squibb Recent Developments
- 4.26 Boehringer Ingelheim Pharmaceuticals
- 4.26.1 Boehringer Ingelheim Pharmaceuticals Company Information
- 4.26.2 Boehringer Ingelheim Pharmaceuticals Business Overview
- 4.26.3 Boehringer Ingelheim Pharmaceuticals Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.26.4 Boehringer Ingelheim Pharmaceuticals Anti-thrombotic Drugs Product Portfolio
- 4.26.5 Boehringer Ingelheim Pharmaceuticals Recent Developments
- 4.27 Bayer
- 4.27.1 Bayer Company Information
- 4.27.2 Bayer Business Overview
- 4.27.3 Bayer Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.27.4 Bayer Anti-thrombotic Drugs Product Portfolio
- 4.27.5 Bayer Recent Developments
5 Global Anti-thrombotic Drugs Market Scenario by Region
- 5.1 Global Anti-thrombotic Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Anti-thrombotic Drugs Sales by Region: 2021-2032
- 5.2.1 Global Anti-thrombotic Drugs Sales by Region: 2021-2026
- 5.2.2 Global Anti-thrombotic Drugs Sales by Region: 2027-2032
- 5.3 Global Anti-thrombotic Drugs Revenue by Region: 2021-2032
- 5.3.1 Global Anti-thrombotic Drugs Revenue by Region: 2021-2026
- 5.3.2 Global Anti-thrombotic Drugs Revenue by Region: 2027-2032
- 5.4 North America Anti-thrombotic Drugs Market Facts & Figures by Country
- 5.4.1 North America Anti-thrombotic Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Anti-thrombotic Drugs Sales by Country (2021-2032)
- 5.4.3 North America Anti-thrombotic Drugs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Anti-thrombotic Drugs Market Facts & Figures by Country
- 5.5.1 Europe Anti-thrombotic Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Anti-thrombotic Drugs Sales by Country (2021-2032)
- 5.5.3 Europe Anti-thrombotic Drugs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Anti-thrombotic Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific Anti-thrombotic Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Anti-thrombotic Drugs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Anti-thrombotic Drugs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Anti-thrombotic Drugs Market Facts & Figures by Country
- 5.7.1 South America Anti-thrombotic Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Anti-thrombotic Drugs Sales by Country (2021-2032)
- 5.7.3 South America Anti-thrombotic Drugs Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Anti-thrombotic Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Anti-thrombotic Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Anti-thrombotic Drugs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Anti-thrombotic Drugs Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Anti-thrombotic Drugs Sales by Type (2021-2032)
- 6.1.1 Global Anti-thrombotic Drugs Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Anti-thrombotic Drugs Sales Market Share by Type (2021-2032)
- 6.2 Global Anti-thrombotic Drugs Revenue by Type (2021-2032)
- 6.2.1 Global Anti-thrombotic Drugs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Anti-thrombotic Drugs Revenue Market Share by Type (2021-2032)
- 6.3 Global Anti-thrombotic Drugs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Anti-thrombotic Drugs Sales by Application (2021-2032)
- 7.1.1 Global Anti-thrombotic Drugs Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Anti-thrombotic Drugs Sales Market Share by Application (2021-2032)
- 7.2 Global Anti-thrombotic Drugs Revenue by Application (2021-2032)
- 7.2.1 Global Anti-thrombotic Drugs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Anti-thrombotic Drugs Revenue Market Share by Application (2021-2032)
- 7.3 Global Anti-thrombotic Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Anti-thrombotic Drugs Value Chain Analysis
- 8.1.1 Anti-thrombotic Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Anti-thrombotic Drugs Production Mode & Process
- 8.2 Anti-thrombotic Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Anti-thrombotic Drugs Distributors
- 8.2.3 Anti-thrombotic Drugs Customers
9 Global Anti-thrombotic Drugs Analyzing Market Dynamics
- 9.1 Anti-thrombotic Drugs Industry Trends
- 9.2 Anti-thrombotic Drugs Industry Drivers
- 9.3 Anti-thrombotic Drugs Industry Opportunities and Challenges
- 9.4 Anti-thrombotic Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$2,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst